1. Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States. (3rd July 2017) Authors: Saint-Laurent Thibault, Catherine; Moorjaney, Divya; Ganz, Michael L.; Sill, Bruce; Hede, Shalini; Yuan, Yong; Gorsh, Boris Journal: Journal of medical economics Issue: Volume 20:Number 7(2017) Page Start: 692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Reply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States. (2nd November 2017) Authors: Saint-Laurent Thibault, Catherine; Moorjaney, Divya; Ganz, Michael L.; Sill, Bruce; Hede, Shalini; Yuan, Yong; Gorsh, Boris Journal: Journal of medical economics Issue: Volume 20:Number 11(2017) Page Start: 1123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗